The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in England

• Published in: Antimicrobial resistance & infection control 2023-09, Vol.12 (1), p.102-102, Article 102
• Main Authors: Yang, Ya-Ting, Zhong, Xiaomin, Fahmi, Ali, Watts, Simon, Ashcroft, Darren M, Massey, Jon, Fisher, Louis, MacKenna, Brian, Mehrkar, Amir, Bacon, Sebastian C J, Goldacre, Ben, Hand, Kieran, van Staa, Tjeerd, Palin, Victoria
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents - therapeutic use; Antibiotic stewardship; Antibiotics; Antimicrobial agents; Body mass index; Care and treatment; Chronic obstructive pulmonary disease; Codes; Communicable Disease Control; Comorbidity; COVID-19; COVID-19 - epidemiology; COVID-19 pandemic; Disease control; Diseases; Drug resistance; Drug resistance in microorganisms; Ear diseases; Electronic health records; England - epidemiology; Epidemics; Health aspects; Horses; Hospitals; Humans; Illnesses; Infection; Infections; Medical research; Medicine; Medicine, Experimental; Pandemics; Patient admissions; Population; Practice; Prescriptions; Primary care; Primary Health Care; Respiratory tract; Respiratory Tract Infections - drug therapy; Respiratory Tract Infections - epidemiology; Retrospective Studies; United Kingdom; Urinary tract infections
• ISSN: 2047-2994; 2047-2994
• DOI: 10.1186/s13756-023-01280-6

There is concern that the COVID-19 pandemic altered the management of common infections in primary care. This study aimed to evaluate infection-coded consultation rates and antibiotic use during the pandemic and how any change may have affected clinical outcomes. With the approval of NHS England, a retrospective cohort study using the OpenSAFELY platform analysed routinely collected electronic health data from GP practices in England between January 2019 and December 2021. Infection coded consultations and antibiotic prescriptions were used estimate multiple measures over calendar months, including age-sex adjusted prescribing rates, prescribing by infection and antibiotic type, infection consultation rates, coding quality and rate of same-day antibiotic prescribing for COVID-19 infections. Interrupted time series (ITS) estimated the effect of COVID-19 pandemic on infection-coded consultation rates. The impact of the pandemic on non- COVID-19 infection-related hospitalisations was also estimated. Records from 24 million patients were included. The rate of infection-related consultations fell for all infections (mean reduction of 39% in 2020 compared to 2019 mean rate), except for UTI which remained stable. Modelling infection-related consultation rates highlighted this with an incidence rate ratio of 0.44 (95% CI 0.36-0.53) for incident consultations and 0.43 (95% CI 0.33-0.54) for prevalent consultations. Lower respiratory tract infections (LRTI) saw the largest reduction of 0.11 (95% CI 0.07-0.17). Antibiotic prescribing rates fell with a mean reduction of 118.4 items per 1000 patients in 2020, returning to pre-pandemic rates by summer 2021. Prescribing for LRTI decreased 20% and URTI increased 15.9%. Over 60% of antibiotics were issued without an associated same-day infection code, which increased during the pandemic. Infection-related hospitalisations reduced (by 62%), with the largest reduction observed for pneumonia infections (72.9%). Same-day antibiotic prescribing for COVID-19 infection increased from 1 to 10.5% between the second and third national lockdowns and rose again during 2022. Changes to consultations and hospital admissions may be driven by reduced transmission of non-COVID-19 infections due to reduced social mixing and lockdowns. Inconsistencies in coding practice emphasises the need for improvement to inform new antibiotic stewardship policies and prevent resistance to novel infections.